Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Athersys and Santarus

Continue Reading

Amount of Special Dividend Payments in 2012 Currently Four Times the Amount Seen in 2011

Five Star Equities Provides Stock Research on Altria Group and Johnson & Johnson

Continue Reading

U.S. Coal Demand Declined 9.9% in 2012 — 34,700 Megawatts of Coal-Fired Generators to Be Shut Down From Now to 2020

The Paragon Report Provides Stock Research on Arch Coal and CONSOL Energy

Continue Reading

End of Dividend Top Tax Rate of 15% a Major Concern for Dividend Investors in the New Year

Five Star Equities Provides Stock Research on Chimera and Hatteras Financial

Continue Reading

Medical Device Excise Tax to Have a Significant Impact on Industry Profits in the New Year

The Paragon Report Provides Stock Research on MAKO Surgical and Stryker

Continue Reading

Number of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase Looms

Five Star Equities Provides Stock Research on Philip Morris and Cablevision Systems

Continue Reading

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Lexicon Pharmaceuticals and Oncothyreon

Continue Reading

Coal Companies Lost 93 Million Tons Worth of Demand in 2012 Due to Warmer Temperatures and Cheap Natural Gas

The Paragon Report Provides Stock Research on Alpha Natural Resources and James River Coal

Continue Reading

Medical Devices Industry Profits to Suffer as Medical Device Excise Tax of 2.3% Set to Kick In

The Paragon Report Provides Stock Research on Edwards Lifesciences and Zimmer Holdings

Continue Reading

Cheap Natural Gas and Warm Temperatures Caused Coal Demand to Decline by 93 Million Tons in 2012

The Paragon Report Provides Stock Research on Peabody Energy and Walter Energy

Continue Reading